Morgan Stanley stock price rises as traders brace for Fed decision and policy risk
26 January 2026
1 min read

Morgan Stanley stock price rises as traders brace for Fed decision and policy risk

NEW YORK, Jan 26, 2026, 13:30 (EST) — Regular session

  • Morgan Stanley shares climbed 1.5% in afternoon trading, outperforming most of its large U.S. banking peers
  • Investors are bracing ahead of Wednesday’s Federal Reserve policy announcement
  • Washington headlines about banks and credit card rates continue to sway the market

Morgan Stanley shares climbed 1.5%, reaching $181.61 in early afternoon trading on Monday. During the session, the stock fluctuated between $178.00 and $182.27.

Investors are bracing for a U.S. Federal Reserve meeting kicking off Tuesday, alongside a packed week of mega-cap earnings—events that could swiftly alter risk appetite. Chris Larkin at E*Trade, affiliated with Morgan Stanley, warned that Wednesday’s Fed announcement “will likely keep politics in the headlines.” Reuters

For Morgan Stanley, the balance is key. Its trading and wealth management arms gain from steady client activity, but the investment bank depends heavily on deal flow—which can stall when market sentiment turns cautious.

Shares followed the broader banking sector on Monday. Goldman Sachs climbed roughly 1.1%, Wells Fargo added 1.3%, JPMorgan increased by 0.8%, and Bank of America rose 0.7%.

Investors continue to digest Morgan Stanley’s January 15 earnings, which topped profit forecasts thanks to a surge in dealmaking and underwriting. Investment banking revenue soared 47%, while CFO Sharon Yeshaya told Reuters the firm is witnessing “an accelerating pipeline” in both mergers and acquisitions (M&A) and initial public offerings (IPOs). Reuters

Washington remains a factor for bank stocks. President Donald Trump’s escalating feud with Wall Street now features a lawsuit targeting JPMorgan and a push for a one-year 10% cap on credit card interest rates. Banks caution the move could restrict access to credit.

The most straightforward risk this week is a policy shock rattling rates markets. The Fed is widely expected to keep rates unchanged at 3.50%-3.75%. Still, it faces renewed pressure on its independence following a Justice Department probe into Chair Jerome Powell. This development could unsettle bond yields and bank stocks.

Wednesday’s Fed decision takes center stage, followed closely by guidance from major tech earnings this week. These factors will determine if the broader rally holds—and if Morgan Stanley and its rivals maintain their upward momentum.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Icade (ENXTPA:ICAD) Seen 11% Below Fair Value After Soft H1 2026 Performance and Chairman Change
    July 25, 2026, 1:36 AM EDT. Icade posted softer H1 2026 results, citing reduced sales and a greater net loss, while Raphael Appert was named Chairman. The stock fell 10.33% YTD to €19.28 and the five-year total return is down 50.43%, though analysts estimate Icade remains 11% undervalued, assigning a fair value of €21.67. Growth prospects are supported by ESG and green financing initiatives, though ongoing revenue headwinds and higher leverage present challenges.
Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Previous Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom
Next Story

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom